At a bankruptcy hearing Tuesday morning, Prospect Medical Holdings is expected to provide an update on the status of ...

Biodexa Pharmaceuticals (BDRX) announced the results of its Type C meeting with the U.S. Food and Drug Administration, FDA, regarding the ...

Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAPClears the way to ...

This €1.6 Million financing will allow MSInsight to finalize MSIcare's technological development, demonstrate its performance ...